Abstract
Twenty-one (three groups of seven), men and women, 25–50 years of age were studied to determine whether or not rebound insomnia would increase the likelihood of self administering a benzodiazepine (triazolam 0.25 mg) hypnotic. The groups compared were patients with insomnia and disturbed sleep, insomnia and normal sleep, and healthy normals. Rebound insomnia, by both subjective and polysomnographic assessment, was induced. The experience of rebound insomnia did not increase the likelihood of self administering a benzodiazepine hypnotic in any of the groups. There were clear group differences in pill self administration with normals rarely and insomnia patients frequently, but not differentially (placebo versus active drug) self administering pills.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Psychiatric Association (1990) Benzodiazepine dependence, toxicity, and abuse. American Psychiatric Association, Washington, DC
Bixler E, Kales A, Soldatos C, Scharf M, Kales J. (1978) Effectiveness of temazepam with short-, intermediate-, and long-term use: sleep laboratory evaluation. J Clin Pharmacol 18:110–118
Consensus Conference (1984) Drugs and insomnia. JAMA 251:2410–2414
de Wit H, Johanson CE, Uhlenhuth EH (1984) Reinforcing properties of lorazepam in normal volunteers. Drug Alcohol Depend 13:31–41
Greenblatt D, Harmatz J, Zinny M, Shader R (1987) Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. New Engl J Med 12:722–728
Griffiths RR, Roache JD (1985) Abuse liability of benzodiazepines: A review of human studies evaluating subjective and/or rein-forcing effects. In: Smith DE, Wesson DR (eds) The benzodiazepines current standards for medical practice. MTP Press Hingman, MA, pp 209–225
Griffiths RR, Bigelow GE, Liebson I (1979) Human drug self-administration: double blind comparison of pentobarbital, diazepam, chlorpromazine and placebo. J Pharmacol Exp Ther 210:301–310
Griffiths RR, Bigelow GE, Liebson I (1983a) Differential effects of diazepam and pentobarbital on mood and behavior. Arch Gen Psychiatry 40:865–873
Griffiths RR, Bigelow GE, Liebson I, Kaliszak JE (1983b) Drug preference in humans: double blind choice comparison of pentobarbital, diazepam and placebo. J Pharmacol Exp Ther 215:649–661
Griffiths RR, Lamb RJ, Ator NA, Roache JD, Brady JV (1985) Relative abuse liability of triazolam: experimental assessment in animals and humans. Neurosci Biobehav Rev 9:133–151
Hartse K, Roth T, Piccione P, Zorick F (1980) Rebound insomnia. Science 208:423
Johanson CE, Uhlenhuth EH (1980a) Drug preference and mood in humans: diazepam. Psychopharmacology 71:269–273
Johanson CE, Uhlenhuth EH (1980b) Drug preference and mood in humans:d-amphetamine. Psychopharmacology 71:275–279
Johanson CE, Kilgore K, Uhlenhuth EH (1983) Assessment of dependence potential of drugs in humans using multiple indices. Psychopharmacology 81:144–149
Kales A, Scharf M, Kales J (1978) Rebound insomnia: a new clinical syndrome. Science 201:1039–1041
Marks J (1978) The Benzodiazepines — use, overuse, misuse, abuse. University Park Press, Baltimore, MD
Merlotti L, Roehrs T, Zorick F, Stepanski E, Russo L, Roth T (1988) Rebound insomnia, duration of administration, and individual differences. Sleep Res 17:52
Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. US Govt Printing Office, USPHS, Washington DC
Roehrs TA, Zorick FJ, Wittig RM, Roth T (1986) Determinants of rebound insomnia. Br J Clin Pharmacol 22:143–147
Roehrs T, Vogel G, Roth T (1990) Rebound insomnia: its determinants and significance. Am J Med 88:39S-42S
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roehrs, T., Merlotti, L., Zorick, F. et al. Rebound insomnia and hypnotic self administration. Psychopharmacology 107, 480–484 (1992). https://doi.org/10.1007/BF02245259
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245259